Handheld pupillometer may accurately detect functional loss in glaucoma: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-12-09 03:30 GMT   |   Update On 2021-12-09 03:31 GMT
Advertisement

Singapore: Results from a proof-of-concept study have found shown handheld chromatic pupillometry (HCP)  to be helpful in accurate, rapid, and objective detection of functional loss in glaucoma patients. The study was published in the British Journal of Ophthalmology. 

Early detection and treatment of glaucoma can delay vision loss. However, its diagnosis occurs often occurs at a late stage, especially in low-income and middle-income countries, where up to 50% of patients are already blind in one eye at presentation.

Advertisement

Chromatic pupillometry has become increasingly recognized as an effective method for evaluating retinal and optic nerve health. The device measures the pupillary responses to light stimulations of different wavelengths. 

Raymond P Najjar, Visual Neurosciences Research Group, Singapore Eye Research Institute, Singapore, and colleagues aimed to evaluate the pupillary responses to exponentially increasing blue and red light stimulations in patients with different severities of glaucoma using a custom-built handheld pupillometer. 

The researchers enrolled 149 patients (median years: 68.5 years) with confirmed glaucoma and 173 healthy controls (55.2 (26.7) years). They monocularly assessed changes in pupil size in response to 9 s of exponentially increasing blue (469 nm) and red (640 nm) light-stimuli using a custom-built handheld pupillometer. Pupillometric features were extracted from individual traces and compared between groups.

Features with the highest classification potential, selected using a gradient boosting machine technique, were incorporated into a generalized linear model for glaucoma classification. Receiver operating characteristic curve analyses (ROC) were used to compare the performance of HCP, optical coherence tomography (OCT), and Humphrey Visual Field (HVF). 

Based on the study, the researchers found the following:

· Pupillary light responses were altered in glaucoma compared with controls.

· For glaucoma classification, HCP yielded an area under the ROC curve (AUC) of 0.94, a sensitivity of 87.9%, and specificity of 88.4%.

· The classification performance of HCP in early-moderate glaucoma (visual field mean deviation (VFMD) > -12 dB; AUC=0.91) was similar to HVF (AUC=0.91) and reduced compared with OCT (AUC=0.97).

· For severe glaucoma (VFMD ≤ -12 dB), HCP had an excellent classification performance (AUC=0.98) that was similar to HVF and OCT.

"Our findings highlight the feasibility and high accuracy of chromatic pupillometry delivered using a handheld device for the objective detection of functional loss in glaucoma in a clinical setting," wrote the authors. Still, there is a need for community-based or opportunistic screening studies, as well as cost-effectiveness analyses to confirm whether HCP is a useful tool for glaucoma screening.

Reference:

Najjar RP, Rukmini AV, Finkelstein MT, et alHandheld chromatic pupillometry can accurately and rapidly reveal functional loss in glaucomaBritish Journal of Ophthalmology Published Online First: 01 December 2021. doi: 10.1136/bjophthalmol-2021-319938

 

Tags:    
Article Source : British Journal of Ophthalmology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News